• Nie Znaleziono Wyników

Ventricular fibrillation in a marathon mountain bike racer

N/A
N/A
Protected

Academic year: 2022

Share "Ventricular fibrillation in a marathon mountain bike racer"

Copied!
1
0
0

Pełen tekst

(1)

www.kardiologiapolska.pl

Kardiologia Polska 2014; 72, 5: 468; DOI: 10.5603/KP.2014.0097 ISSN 0022–9032

Studium przypadku / CliniCal Vignette

Ventricular fibrillation in a marathon mountain bike racer

Migotanie komór u uczestnika terenowego maratonu rowerowego

Joanna Piniewska-Juraszek, Edyta Kostarska-Srokosz, Wojciech Król, Joanna Syska-Sumińska, Mirosław Dłużniewski

Department of Cardiology, 2nd Medical Faculty, Medical University of Warsaw, Poland

A 41-year-old man with no concomitant chronic diseases, an amateur cyclist and runner, was admitted because of ven- tricular fibrillation preceded by chest pain which took place on a 32 km marathon mountain bike race. After a fourth defibrillation performed by medical emergency services, sinus rhythm was restored and ST-elevations in anterior and lateral leads occurred (Fig. 1). The patient was immediately transferred to the catheterisation laboratory. On admission he was conscious with Glasgow Coma Scale 15. Signs of cardiogenic shock including tachycardia, decreased blood pressure (80/40 mm Hg), tachypnoea and hypoxemia were present. During coronary angiography, left anterior descending (LAD) artery occlusion with proximal thrombus was demonstrated (Fig. 2). Other coronary arteries were normal. After thrombec- tomy, atherosclerotic stenosis of LAD was revealed and consequently a zotarolimus-eluting stent was implanted (Fig. 3).

The patient was treated with glycoprotein IIb/IIIa receptor antagonist. The laboratory tests demonstrated signs of tissue hy- poperfusion: metabolic acidosis (pH = 6.9; base excess = –23), hypoxemia (partial pressure of oxygen = 57 mm Hg, oxygen saturation = 86%), elevated creatinine (270 μmol/L [n < 130]), glucose (16.0 mmol/L [n < 7.7]) and aspartate aminotrans- ferase levels (207 IU/L [n < 35]), and also elevated D-dimer concentration (> 42,000 μg/L [n < 500]). The first measured troponin I level was normal (0.05 μg/L [n < 0.1]). After coro- nary angioplasty, immediate cardiac output improvement was achieved with an increase of oxygen saturation and normalisa- tion of blood pressure. Transthoracic echocardiography deline- ated akinesia limited to the left ventricular apex with preserved global ejection fraction of 55%. During the first day of hospi- talisation, some complications of standard antiplatelet (aspirin, clopidogrel, abciximab) and antithrombotic (unfractionated heparin) treatment appeared. The patient had subconjunctival haemorrhages, a massive haematoma of the tongue affecting swallowing and speech, and nasal mucose membrane bleeding.

These complications are fairly frequently observed in patients with acid-base imbalances and do not require modification of the antiplatelet therapy. Of the risk factors for the development of coronary artery disease (CAD), only abnormal blood lipid level was present (total cholesterol = 6.0 mmol/L, low-density lipoprotein cholesterol = 3.9 mmol/L). This case shows that a combination of extreme physical activity and competition between non professional athletes might be a strong stressor for the cardiovascular system and furthermore a possible cause of sudden cardiac death in individuals with concomitant CAD.

This emphasises the need for thorough medical work-up for people wanting to participate in amateur, organised competi- tion, especially those aged over 35.

Address for correspondence:

Joanna Piniewska-Juraszek, MD, Department of Cardiology, 2nd Medical Faculty, Medical University of Warsaw, ul. Kondratowicza 8, 03–242 Warszawa, Poland, e-mail: joanna.piniewska@gmail.com

Conflict of interest: none declared

Figure 3. A. Proximal LAD stenosis revealed after throm- bectomy; B. Restored normal coronary blood flow in LAD Figure 1. Admission electrocardiogram with ST elevation in anterolateral leads

Figure 2. A. Right coronary artery angiogram; B. Left coronary artery angiogram with occluded LAD and proximal thrombus

A

A

B

B

Cytaty

Powiązane dokumenty

The effect of 90-day simvastatin/ezetimibe combination therapy on plasma lipids, glucose metabolism markers, and circulating levels of high sensitivity C-reactive protein and the

This study was designed retrospectively: 211 premature coronary atherosclerotic patients (pCAP) (36.4 ± 2.5 years) and 160 control subjects (36.4 ± 2.4 years) selected from patients

Celem pracy jest ocena nasilenia oksydatywnej modyfikacji LDL w przebiegu niedoczynności tarczy- cy przez pomiar stężenia utlenionych LDL w osoczu (ox LDL, oxidized low

By constructing dummy combined variables, high leukocyte counts accompanied by smoking, hypertension, diabetes, and high levels of serum glucose, cholesterol, apoB and apoB/apoAI

The aim of the study was to assess the useful- ness of NT-proBNP in the diagnosis of isolated LV diastolic dysfunction in patients with documented coronary disease and preserved

Although the European guidelines on cardiovascular disease prevention are well established, our study demonstrated that patients after percutaneous coronary intervention (PCI)

Key words: arterial wall compliance, arterial wall elasticity, arterial wall stiffness, large arteries, low-density lipoprotein cholesterol, small arteries.. Kardiol Pol 2018; 76,

Severity of coronary artery disease (CAD) was determined by Gensini score; MPV — mean platelet volume; TC — total cholesterol; HDL-C — high density lipoprotein cholesterol;.. PLTc